Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
34
WGLD.V Quote, Financials, Valuation and Earnings
Last price:
$0.22
Seasonality move
:
5.86%
Day range:
$0.22 - $0.22
52-week range:
$0.07 - $1.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.88x
Volume:
3.3K
Avg. volume:
7.3K
1-year change:
3.9%
Market cap:
$4.9M
Revenue:
--
EPS (TTM):
-$0.08
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $2.3K | $9.1K | $6.9K | |
| Gross Profit | -- | -- | -$2.3K | -$9.1K | -$6.9K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.8K | $294.2K | $182.1K | $204.8K | $153.4K | |
| Other Inc / (Exp) | -- | -$31K | -$599.8K | -$1.5K | -$1.2K | |
| Operating Expenses | $1.3M | $1.4M | $2.5M | $1.7M | $1.7M | |
| Operating Income | -$1.3M | -$1.4M | -$2.5M | -$1.7M | -$1.7M | |
| Net Interest Expenses | $3M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$4.3M | -$1.4M | -$2.6M | -$1.7M | -$1.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$67.4K | -- | -- | -- | -- | |
| Net Income to Company | -$4.4M | -$1.4M | -$2.6M | -$1.7M | -$1.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.2M | -$1.4M | -$2.6M | -$1.7M | -$1.7M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.21 | -$0.09 | -$0.04 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.21 | -$0.09 | -$0.04 | -$0.11 | |
| Weighted Average Basic Share | $9.2M | $6.9M | $29.3M | $39.7M | $15.4M | |
| Weighted Average Diluted Share | $9.2M | $6.9M | $29.3M | $39.7M | $15.4M | |
| EBITDA | -$1.3M | -$1.4M | -$2.5M | -$1.7M | -$1.7M | |
| EBIT | -$1.3M | -$1.4M | -$2.5M | -$1.7M | -$1.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$1.3M | -$1.4M | -$2.5M | -$1.7M | -$1.7M | |
| Operating Income (Adjusted) | -$1.3M | -$1.4M | -$2.5M | -$1.7M | -$1.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $2.3K | $2K | $600 | |
| Gross Profit | -- | -- | -$2.3K | -$2K | -$600 | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $107.2K | $69.1K | $67.7K | $11.2K | $36.3K | |
| Other Inc / (Exp) | -- | -$10.7K | -$33.2K | -$5.5K | -- | |
| Operating Expenses | $127.3K | $656.2K | $502.1K | $659.9K | $382K | |
| Operating Income | -$127.3K | -$656.2K | -$504.4K | -$661.9K | -$382.7K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$127.3K | -$656.1K | -$505.5K | -$663K | -$381.5K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$125.1K | -$1.3M | -$400.3K | -$668.2K | -$381.5K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$127.3K | -$656.1K | -$505.5K | -$663K | -$381.5K | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.09 | -$0.01 | -$0.01 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.09 | -$0.01 | -$0.01 | -$0.02 | |
| Weighted Average Basic Share | $26.6M | $7.7M | $39.9M | $67.8M | $22.2M | |
| Weighted Average Diluted Share | $26.6M | $7.7M | $39.9M | $67.8M | $22.2M | |
| EBITDA | -$127.3K | -$656.2K | -$502.1K | -$659.9K | -$382K | |
| EBIT | -$127.3K | -$656.2K | -$504.4K | -$661.9K | -$382.7K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$127.3K | -$656.2K | -$504.4K | -$661.9K | -$382.7K | |
| Operating Income (Adjusted) | -$127.3K | -$656.2K | -$504.4K | -$661.9K | -$382.7K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $9.1K | $8.2K | $2.9K | |
| Gross Profit | -- | -- | -$9.1K | -$8.2K | -$2.9K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $146.8K | $199.2K | $198.4K | $168.3K | $189.9K | |
| Other Inc / (Exp) | -- | -$22.1K | -$689.5K | $1.3K | -- | |
| Operating Expenses | $1.5M | $2.5M | $3.4M | $2.1M | $1.4M | |
| Operating Income | -$1.5M | -$2.5M | -$3.4M | -$2.1M | -$1.4M | |
| Net Interest Expenses | $3M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$4.5M | -$2.6M | -$3.5M | -$2.1M | -$1.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$67.4K | -- | -- | -- | -- | |
| Net Income to Company | -$4.3M | -$2.6M | -$2.1M | -$2.1M | -$1.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.4M | -$2.6M | -$3.5M | -$2.1M | -$1.4M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.35 | -$0.10 | -$0.04 | -$0.08 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.35 | -$0.10 | -$0.04 | -$0.08 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$1.5M | -$2.5M | -$3.4M | -$2.1M | -$1.4M | |
| EBIT | -$1.5M | -$2.5M | -$3.4M | -$2.1M | -$1.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$1.5M | -$2.5M | -$3.4M | -$2.1M | -$1.4M | |
| Operating Income (Adjusted) | -$1.5M | -$2.5M | -$3.4M | -$2.1M | -$1.4M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $6.8K | $5.8K | $1.9K | -- | |
| Gross Profit | -- | -$6.8K | -$5.8K | -$1.9K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $135.5K | $151.1K | $105.6K | $142K | -- | |
| Other Inc / (Exp) | -$22.1K | -$58.4K | -$6.2K | -$40 | -- | |
| Operating Expenses | $1.4M | $1.1M | $1.5M | $1.2M | -- | |
| Operating Income | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$1.5M | -$1M | -$1.5M | -$1.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Basic EPS (Cont. Ops) | -$0.18 | -$0.03 | -$0.03 | -$0.06 | -- | |
| Diluted EPS (Cont. Ops) | -$0.18 | -$0.03 | -$0.03 | -$0.06 | -- | |
| Weighted Average Basic Share | $23.5M | $108.4M | $169M | $58.4M | -- | |
| Weighted Average Diluted Share | $23.5M | $108.4M | $169M | $58.4M | -- | |
| EBITDA | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| EBIT | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Operating Income (Adjusted) | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.1M | $1.4M | $781.5K | $834.6K | $318.4K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $17.8K | $12.5K | -- | $11.5K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.2M | $1.7M | $819.4K | $912K | $331K | |
| Property Plant And Equipment | -- | -- | $22.9K | $13.8K | $6.9K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $6.3M | $2.9M | $1.4M | $1.5M | $891K | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $61K | $60.8K | $100.3K | $38.8K | $42.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61K | $60.8K | $100.3K | $38.8K | $42.3K | |
| Common Stock | $10.2M | $10.2M | $11.2M | $13.2M | $14.3M | |
| Other Common Equity Adj | $39.9K | $57.8K | $55.3K | $42.9K | $32K | |
| Common Equity | $6.3M | $2.8M | $1.3M | $1.4M | $848.7K | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.3M | $2.8M | $1.3M | $1.4M | $848.7K | |
| Total Liabilities and Equity | $6.3M | $2.9M | $1.4M | $1.5M | $891K | |
| Cash and Short Terms | $3.1M | $1.4M | $781.5K | $834.6K | $318.4K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6M | $1.1M | $1.6M | $582.4K | $263.6K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $9.3K | $13K | $2.5K | -- | $2.5K | |
| Other Current Assets | -- | -- | -- | $2.1K | -- | |
| Total Current Assets | $1.7M | $1.4M | $1.6M | $584.8K | $281.3K | |
| Property Plant And Equipment | -- | -- | $16.1K | $7.9K | $5K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $700 | -- | -- | |
| Total Assets | $6M | $6.7M | $2.2M | $1.1M | $839.4K | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $61.5K | $76K | $76.8K | $11.6K | $9.6K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61.5K | $76K | $76.8K | $11.6K | $9.6K | |
| Common Stock | $10.2M | $11.2M | $13M | $14.3M | $15.2M | |
| Other Common Equity Adj | $40K | $15.5K | $46.3K | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6M | $6.6M | $2.1M | $1.1M | $829.8K | |
| Total Liabilities and Equity | $6M | $6.7M | $2.2M | $1.1M | $839.4K | |
| Cash and Short Terms | $1.6M | $1.1M | $1.6M | $582.4K | $263.6K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.4M | -$1.4M | -$2.6M | -$1.7M | -$1.7M | |
| Depreciation & Amoritzation | -- | -- | $2.3K | $9.1K | $6.9K | |
| Stock-Based Compensation | $656.5K | -- | -- | $105.2K | -- | |
| Change in Accounts Receivable | $104.6K | -$186.3K | $257K | -$52.1K | $76.3K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$779.4K | -$1.6M | -$1.7M | -$1.7M | -$1.7M | |
| Capital Expenditures | $450.3K | -- | $25.1K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $263.5K | -- | -$25.1K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $86K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$369.6K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.6M | -- | $1.1M | $1.8M | $1.2M | |
| Beginning Cash (CF) | $3.1M | $1.4M | $781.5K | $334.6K | $318.4K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.1M | -$1.6M | -$666.2K | $53.1K | -$516.2K | |
| Ending Cash (CF) | $6.2M | -$191K | $121.3K | $388.7K | -$197.8K | |
| Levered Free Cash Flow | -$1.2M | -$1.6M | -$1.7M | -$1.7M | -$1.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$125.1K | -$1.3M | -$400.3K | -$668.2K | -$381.5K | |
| Depreciation & Amoritzation | -- | -- | $2.3K | $2K | $600 | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$47.2K | -$21.3K | -$11.9K | $40.2K | $25.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$865.3K | -$1.5M | -$418.7K | -$515.9K | -$386.2K | |
| Capital Expenditures | $214.8K | -$632.2K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$214.8K | $632.2K | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$82.7K | -$143.3K | -$128.2K | -- | |
| Cash From Financing | -- | $1.1M | $1.8M | -$700 | -- | |
| Beginning Cash (CF) | $1.6M | $1.1M | $1.6M | $582.4K | $263.6K | |
| Foreign Exchange Rate Adjustment | -- | -$23K | $500 | $2.4K | -$1.8K | |
| Additions / Reductions | -$1.1M | $221.4K | $1.3M | -$474.3K | -$388K | |
| Ending Cash (CF) | $479.1K | $1.3M | $2.9M | $110.5K | -$126.2K | |
| Levered Free Cash Flow | -$1.1M | -$822.9K | -$418.7K | -$515.9K | -$386.2K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.3M | -$2.6M | -$2.1M | -$2.1M | -$1.4M | |
| Depreciation & Amoritzation | -- | -- | $9.1K | $8.2K | $2.9K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $11.7K | -$119.1K | $228K | $62.8K | -$14.9K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$820.7K | -$2.7M | -$1.3M | -$2.1M | -$1.5M | |
| Capital Expenditures | $1.4M | -$1.2M | $25.1K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$669K | $1.2M | -$25.1K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2.8M | $1.1M | $1.8M | $1.1M | $1.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4M | -$488K | $484.9K | -$973.8K | -$318.8K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.2M | -$1.5M | -$1.3M | -$2.1M | -$1.5M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.5M | -$1M | -$1.5M | -$1.2M | -- | |
| Depreciation & Amoritzation | -- | $6.8K | $5.8K | $1.9K | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$8.8K | -$37.8K | $77.1K | -$14.1K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.4M | -$978.8K | -$1.4M | -$1.2M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$82.7K | -$143.3K | -$128.2K | -- | -- | |
| Cash From Financing | $1.1M | $1.8M | $1.1M | $1.2M | -- | |
| Beginning Cash (CF) | $3.2M | $2.3M | $1.3M | $1M | -- | |
| Foreign Exchange Rate Adjustment | -$33.8K | -$500 | $3.3K | $0 | -- | |
| Additions / Reductions | -$376.4K | $774.7K | -$252.3K | -$54.8K | -- | |
| Ending Cash (CF) | $2.7M | $3.1M | $1M | $962.9K | -- | |
| Levered Free Cash Flow | -$1.4M | -$978.8K | -$1.4M | -$1.2M | -- | |
Get WGLD.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
WGLD.V
Sector
P/E ratio
--
--
PEG ratio
-0.03x
--
P/B ratio
5.88x
--
Price / LTM sales
--
--
Growth Metrics
WGLD.V
Sector
Revenue growth
--
--
Earnings growth
-75.51%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
WGLD.V
Sector
Profitability FY 2024
-$6.9K
--
Return on invested capital
-155.77%
--
Return on assets
-150.72%
--
Return on equity
-155.77%
--
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
WGLD.V
Sector
Total cash
$263.6K
--
Short term investments
--
--
Total assets
$891K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
